Phase 3 Study of FOLFIRINOX (mFFX) +/- SBRT in Locally Advanced Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Leucovorin
Related studies linked through entity extraction aliases.
A Novel "Pediatric-Inspired" Regimen With Reduced Myelosuppressive Drugs for Adults (Aged 18-60) With Newly Diagnosed Ph Negative Acute Lymphoblastic Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
FOLFOX Plus Regorafenib in Patients With Unresectable or Metastatic Esophagogastric Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Ipatasertib (GDC-0068) in Combination With Fluoropyrimidine Plus Oxaliplatin in Participants With Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Chemotherapy and Radiation Therapy Before Surgery Followed by Gemcitabine in Treating Patients with Pancreatic Cancer
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Study to Evaluate the Safety and Tolerability of Andecaliximab as Monotherapy and in Combination With Chemotherapy in Participants With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Sorafenib + mFOLFOX for Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
FOLFOX +/- Ziv-Aflibercept for Esophageal and Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Methotrexate Infusion Into the Fourth Ventricle in Children With Malignant Fourth Ventricular Brain Tumors: A Pilot Study
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
NEOadjuvant Trial in Adenocarcinoma of the oEsophagus and oesophagoGastric Junction International Study (Neo-AEGIS)
- Status
- COMPLETED
- Phase
- PHASE3
Phase II Study Using CHFR Methylation Status in Patients With Metastatic Esophageal, Gastroesophageal, Gastric Cancer.
- Status
- COMPLETED
- Phase
- PHASE2
Colorectal Cancer Metastatic
- Status
- COMPLETED
- Phase
- PHASE3
A Pilot Study of Pre- and Post-surgery Chemotherapy With mFOLFIRINOX in Localized, Resectable Pancreatic Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Study to Evaluate Safety & Tolerability of BMS-906024 in Combination With Chemotherapy & to Define DLTs & MTD of BMS-906024 in Combination With One of the Following Chemotherapy Regimens; Weekly Paclitaxel, 5FU+Irinotecan or Carboplatin+Paclitaxel in Subjects With Advanced / Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Efficacy Study of MEHD7945A + FOLFIRI Versus Cetuximab + FOLFIRI as Second Line Therapy in Participants With KRAS Wild-Type Metastatic Colorectal Cancer (mCRC)
- Status
- COMPLETED
- Phase
- PHASE2
Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Atezolizumab Administered in Combination With Bevacizumab and/or With Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Translational Study of Bevacizumab in Participants With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE4
Efficacy and Safety Study of Recombinant Endostatin Combined With Chemotherapy to Treat Advanced Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Individual Dosage Selection of Irinotecan (CPT-11) Based on UGT1A1 Genotype in Metastatic Colorectal Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3